Oral Glucose Tolerance Testing After Gestational Diabetes
NCT ID: NCT02082301
Last Updated: 2020-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
118 participants
OBSERVATIONAL
2012-10-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening
NCT07332416
Immediate Postpartum Glucose Tolerance Testing
NCT04199676
Pregnancy and Postpartum CGM in GDM
NCT07174245
Women With Minor Degrees of Glucose Intolerance and the Postpartum Glucose Tolerance Test
NCT03623412
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
NCT06184373
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gestational diabetes
Primary cohort is women with diagnosis of gestational diabetes without evidence of overt diabetes
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational diabetes
Exclusion Criteria
* pre-pregnancy diabetes
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Loyola University
OTHER
MetroHealth Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ted Waters
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thaddeus Waters, MD
Role: PRINCIPAL_INVESTIGATOR
Loyola University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Cleveland, Ohio, United States
MetroHealth Medical Center
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Waters TP, Kim SY, Sharma AJ, Schnellinger P, Bobo JK, Woodruff RT, Cubbins LA, Haghiac M, Minium J, Presley L, Wolfe H, Hauguel-de Mouzon S, Adams W, Catalano PM. Longitudinal changes in glucose metabolism in women with gestational diabetes, from late pregnancy to the postpartum period. Diabetologia. 2020 Feb;63(2):385-394. doi: 10.1007/s00125-019-05051-0. Epub 2019 Dec 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB12-00581
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.